<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width,initial-scale=1.0">
    <link href="style/css/main.css" rel="stylesheet">
    <script src="//ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.9.4/umd/popper.min.js"></script>
    <script src="js/vendor/bootstrap.min.js"></script>
    <script src="js/front-end/stickyHeader.js"></script>
    <script src="js/front-end/notifyTray.js"></script>
    <script src="js/front-end/searchToggle.js"></script>
    <script src="js/front-end/notifyMainToggle.js"></script>
    <script src="js/front-end/headerMainNavMainToggle.js"></script>
    <script src="js/front-end/navMainSubToggleMobile.js"></script>
    <script src="js/front-end/swapBackground.js"></script>
    <script src="js/front-end/navMainSubColumns.js"></script>
    <script src="https://use.fontawesome.com/3942864d90.js"></script>
    <title>RAS Story</title>
  </head>
  <body>
    <form>
      <div class="pageWrap">
        <div class="notifyMain">
          <div class="notifyMain-inner">
            <div class="notifyMain-content">
              <h2 class="notifyMain-heading">Indication and Limitation of use</h2>
              <div class="notifyMain-copy">
                <p>Vectibix® is indicated for the treatment of patients with wild‑type RAS metastatic colorectal cancer (mCRC). Wild‑type RAS is defined as wild‑type in both KRAS and NRAS as determined by an FDA‑approved test for this use: </p>
                <ul>
                  <li>As first‑line therapy in combination with FOLFOX  </li>
                  <li>As monotherapy following disease progression after prior treatment with fluoropyrimidine‑, oxaliplatin‑, an  irinotecan‑containing chemotherapy </li>
                </ul>
                <p>Limitation of Use: Vectibix<sup>&reg;</sup>is not indicated for the treatment of patients with RAS‑mutant mCRC or for whom RAS mutation status is unknown.  </p>
              </div>
            </div>
            <div class="notifyMain-close"></div>
          </div>
        </div>
        <header class="headerMain">
          <div class="headerMain-util">
            <div class="headerMain-utilInner">
              <ul class="headerMain-navUtil">
                <li class="headerMain-navUtilItem"><a class="headerMain-navUtilLink" href="">Link Number One</a></li>
                <li class="headerMain-navUtilItem"><a class="headerMain-navUtilLink" href="">Link Number Two</a></li>
                <li class="headerMain-navUtilItem"><a class="headerMain-navUtilLink" href="">Link Number Three</a></li>
                <li class="headerMain-navUtilItem"><a class="headerMain-navUtilLink" href="">Link Number Four</a></li>
                <li class="headerMain-navUtilItem"><a class="headerMain-navUtilLink" href="">Link Number Five</a></li>
              </ul>
              <div class="headerMain-utilCollateral"><a class="headerMain-ctaBtn" href="">Visit Patient Site</a>
                <div class="headerMain-search">
                  <label for="headerMainSearch"></label>
                  <input class="headerMain-searchBox" type="text" placeholder="Search" id="headerMainSearch"><span class="headerMain-searchToggle"></span>
                </div>
              </div>
              <ul class="headerMain-navUtilMobile">
                <li class="headerMain-navUtilMobileItem"><a class="headerMain-navUtilMobileLink" href="">Link Number One</a></li>
                <li class="headerMain-navUtilMobileItem"><a class="headerMain-navUtilMobileLink" href="">Link Number Two</a></li>
                <li class="headerMain-navUtilMobileItem"><a class="headerMain-navUtilMobileLink" href="">Link Number Three</a></li>
              </ul>
            </div>
          </div>
          <div class="headerMain-main">
            <div class="headerMain-mainInner">
              <div class="headerMain-logo"><a class="headerMain-logoLink" href=""><img class="headerMain-logoImg" src="img/content-images/logo-main.png"></a></div>
              <ul class="headerMain-navMain">
                <li class="headerMain-navMainItem is-current"><a class="headerMain-navMainLink" href=""> <em class="px-1">RAS </em>Story</a>
                  <div class="headerMain-subContent">
                    <div class="headerMain-subContentInner">
                      <ul class="headerMain-subNav">
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href=""> <em class="px-1">KRAS </em>and<em class="px-1">NRAS </em></a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">WT <em class="px-1">RAS </em>in PRIME</a></li>
                      </ul>
                      <div class="headerMain-subcollateral"><a class="headerMain-subcollateralCta" href="">See efficacy in WT RAS mCRC patients from PRIME</a></div>
                    </div>
                  </div>
                </li>
                <li class="headerMain-navMainItem"><a class="headerMain-navMainLink" href="">First-line data</a>
                  <div class="headerMain-subContent">
                    <div class="headerMain-subContentInner">
                      <ul class="headerMain-subNav">
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">Study design</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">Progression-free survival</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">Objective response rate</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">Overall survival</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">Prime safety Profile</a></li>
                      </ul>
                      <div class="headerMain-subcollateral"><a class="headerMain-subcollateralCta" href="">Learn how WT <em>RAS</em>mCRC patients were identified in PRIME</a></div>
                    </div>
                  </div>
                </li>
                <li class="headerMain-navMainItem"><a class="headerMain-navMainLink" href="">Third-line data</a>
                  <div class="headerMain-subContent">
                    <div class="headerMain-subContentInner">
                      <ul class="headerMain-subNav">
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">0007 Study</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">ASPECCT Study</a></li>
                      </ul>
                      <div class="headerMain-subcollateral"><a class="headerMain-subcollateralCta" href="">What clinical characteristics affect your third-line treatment decision?</a></div>
                    </div>
                  </div>
                </li>
                <li class="headerMain-navMainItem"><a class="headerMain-navMainLink" href="">Administration</a></li>
                <li class="headerMain-navMainItem"><a class="headerMain-navMainLink" href="">Patient Profiles</a>
                  <div class="headerMain-subContent">
                    <div class="headerMain-subContentInner">
                      <ul class="headerMain-subNav">
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">First-line: Roy</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">First-line: Brian</a></li>
                        <li class="headerMain-subNavItem"><a class="headerMain-subMainLink" href="">First-line: Connie</a></li>
                      </ul>
                      <div class="headerMain-subcollateral"><a class="headerMain-subcollateralCta" href="">Learn how WT <em>RAS</em>mCRC patients were identified in PRIME</a></div>
                    </div>
                  </div>
                </li>
                <li class="headerMain-navMainItem"><a class="headerMain-navMainLink" href="">Access</a></li>
              </ul>
              <div class="headerMain-navMainToggle">
                <div class="headerMain-navMainToggleLine"></div>
                <div class="headerMain-navMainToggleLine"></div>
                <div class="headerMain-navMainToggleLine"></div>
              </div>
            </div>
          </div>
        </header>
        <main>
          <div class="hero" style="background-image:url(img/content-images/hero.png);">
            <div class="hero-inner">
              <div class="hero-copy"><span class="hero-zone1">In the first-line treatment of mCRC<sup>1 </sup></span><span class="hero-zone2">Biomarker identification can provide critical information<sup>2</sup></span></div>
            </div>
          </div>
          <section class="py-12">
            <div class="container">
              <h2 class="colorBrandBlue">KRAS and NRAS are part of the<br>RAS family of oncogenes<sup>1 </sup></h2>
              <div class="row">
                <div class="col-md-5 colorGrayDark pt-md-10">
                  <p class="textLg">RAS status definitions<sup>2</sup>:</p>
                  <ul class="textLg">
                    <li>RAS mutation negative, or wild type (WT), means the RAS genes (KRAS and NRAS) do not have mutations</li>
                    <li>RAS mutation positive, or mutant type (MT), means that at least one of the RAS genes (KRAS or NRAS) contains a mutation that affects its function</li>
                  </ul>
                </div>
                <div class="col-md-7">
                  <figure><img class="d-md-none" src="img/content-images/kras-exor-2-analysis-sm.svg"><img class="d-none d-md-block" src="img/content-images/kras-exor-2-analysis-lg.svg"></figure>
                </div>
              </div>
              <p class="colorGrayDark">mCRC = metastatic colorectal cancer; MT = mutant type; WT = wild type.</p>
            </div>
          </section>
          <section class="py-12 fillGradientBlue">
            <div class="container">
              <div class="row">
                <div class="col-md-9">
                  <p class="colorBrandOrangeLight textLg">Don't let patients with WT RAS* mCRC miss a chance for personalized treatment<sup>1 </sup></p>
                  <h2 class="fontDefault h1">The power of biomarker identification</h2>
                  <hr class="hr--fade">
                  <h3 class="h2">Identification of patients with WT RAS mCRC can help determine appropriate treatment options<sup>1</sup></h3>
                  <figure class="mb-5"><img class="shadow d-md-none" src="img/content-images/prime-population-sm.svg"><img class="shadow d-none d-md-block" src="img/content-images/prime-population-lg.svg"></figure>
                </div>
              </div>
              <h3 class="h2 mb-5">Vectibix® delivers efficacy for patients with WT<em class="px-1">RAS </em>mCRC<sup>1 </sup></h3>
              <ul class="mb-5 pl-3">
                <li>Patients with MT RAS tumors should not be treated with Vectibix<sup>&reg; 1</sup></li>
              </ul>
              <blockquote class="my-5">"All patients with metastatic colorectal cancer should have tumor tissue genotyped for RAS (KRAS and NRAS) mutations"
                <cite>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines<sup>®</sup>) for Colon Cancer<sup>3</sup></cite>
              </blockquote>
              <p class="pullFirstChar mb-0">*Defined as wild type in both <em>KRAS </em>and <em>NRAS.</em><sup>1</sup></p>
              <p class="pullFirstChar">&dagger;Exon 2 in codons 12 or 13.<sup>1</sup><br>mCRC = metastatic colorectal cancer; MT = mutant type; NCCN = National Comprehensive Cancer Network; PRIME = Panitumumab Randomized Trial in Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy; WT = wild type.</p>
            </div>
          </section>
          <div class="container">
            <div class="inlined py-16 colorGrayDark">
              <h2 class="h5">References:</h2>
              <ol>
                <li> Vectibix<sup>®</sup> (panitumumab) prescribing information, Amgen. </li>
                <li> Douillard J-Y, Oliner KS, Siena S, et al. Panitumumab–FOLFOX4 treatment and <em>RAS</em> mutations in colorectal cancer. <em>N Engl J Med.</em> 2013;369(11):1023-1034. </li>
                <li> Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines<sup>®</sup>) for Colon Cancer V2.2017. ©National Comprehensive Cancer Network, Inc 2017. All rights reserved. Accessed April 21, 2017. To view the most recent and complete version of the guideline, go online to NCCN.org. The National Comprehensive Cancer Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.</li>
              </ol>
            </div>
            <div class="notifyTray is-sticky">
              <div class="notifyTray-inner">
                <div class="notifyTray-content">
                  <h2>IMPORTANT SAFETY INFORMATION</h2>
                  <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. </p>
                  <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. </p>
                  <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. </p>
                  <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. </p>
                  <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. </p>
                  <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. </p>
                </div>
                <div class="notifyTray-toggle">See More</div>
              </div>
            </div>
          </div>
        </main>
        <footer class="footerMain"><a class="footerMain-topLink" href="#pageTop">Back To Top<i class="footerMain-topLinkIcon fa-chevron-up"></i></a>
          <div class="footerMain-inner">
            <div class="footerMain-main">
              <ul class="footerMain-nav">
                <li class="footerMain-navItem"><a class="footerMain-navLink" href="">Link Number One</a></li>
                <li class="footerMain-navItem"><a class="footerMain-navLink" href="">Link Number Two</a></li>
                <li class="footerMain-navItem"><a class="footerMain-navLink" href="">Link Number Three</a></li>
                <li class="footerMain-navItem"><a class="footerMain-navLink" href="">Link Number Four</a></li>
                <li class="footerMain-navItem"><a class="footerMain-navLink" href="">Link Number Five</a></li>
              </ul>
              <div class="footerMain-logo"><a class="footerMain-logoLink" href=""><img class="footerMain-logoImg" src="http://placehold.it/165x50"></a></div>
            </div>
            <div class="footerMain-collateral">
              <p>2017 &copy; Amgen Inc. All rights reserved.</p>
              <p>This website is intended for US healthcare professionals only.</p>
            </div>
          </div>
        </footer>
      </div>
    </form>
  </body>
</html>